Development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukæmia in children

Project Information

LOULLA&PHILLA

Grant agreement ID: 223401

Project closed

Start date 1 November 2008

End date 30 April 2012

Funded under

• Specific Programme "Cooperation": Health

Total cost € 4 244 817,47

EU contribution € 3 316 415,00

Coordinated by

Only For Children Pharmaceuticals
France